Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia

BMC Cancer

Volumn 3, Issue , 2003, Pages

  Terry, Mary Beth ^a,b   Neugut, Alfred I ^a,b   Mansukhani, Mahesh ^b   Waye, Jerome ^c   Harpaz, Noam ^c   Hibshoosh, Hanina ^b  

^a Mailman School of Public Health ^*  (United States)

^b Columbia University ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal adenoma; Colorectal cancer; p53; Risk factors

Indexed keywords

IMMUNOGLOBULIN G2A ANTIBODY; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN P53;

ADENOMATOUS POLYP; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BEER; CANCER CENTER; CANCER INVASION; CANCER TISSUE; CARCINOMA IN SITU; CIGARETTE SMOKING; COLON ADENOMA; COLON MUCOSA; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DESCENDING COLON; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; RECTUM ADENOMA; RECTUM POLYP; RISK ASSESSMENT; RISK FACTOR; AGE; ANALYSIS OF VARIANCE; CARCINOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; DRINKING BEHAVIOR; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; RISK; SMOKING; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; CARCINOMA; CARCINOMA IN SITU; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042800708     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-29     Document Type: Article

References (36)

1. Fearon ER and Volgelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
2. Cho KR and Volgelstein B: Genetic alterations in the adenoma-carcinoma sequence. Cancer 1992, 70:1727-1731.
3. Fearon ER: Molecular genetic studies of the adenoma-carcinoma sequence. Adv Int Med 1994, 39:123-147.
4. Hamilton SR: The molecular genetics of colorectal neoplasia. Gastroenterology 1993, 105:3-7.
5. Ilyas M and Talbot IC: p53 expression in ulcerative colitis: a longitudinal study. Gut 1995, 37:802-804.
6. Pignatelli M, Stamp GWH, Kafiri G, Lane D and Bodmer WF: Overexpression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992, 50:683-688.
7. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukayama M, Koike M and Mori T: Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Research 1992, 52:3965-3971.
8. Hamilton SR: Molecular genetics of colorectal carcinoma. Cancer 1992, 70:1216-1221.
9. Purdie CA, O'Grady J, Piris J, Wyllie AH and Bird CC: p53 Expression in colorectal tumors. American Journal of Pathology 1991, 138:807-813.
10. Voskuil DW, Kampman E, van Kraats AA, Balder HF, van Muijen GN, Goldbohm RA and van't Veer P: p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors. Int J Cancer 1999, 81:675-681.
11. Tsuda H and Hirohashi S: Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. International Journal of Cancer 1994, 57:498-503.
12. Iggo R, Gatter K, Barter J, Lane D and Harris AL: Increase expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990, 335:675-679.
13. Sameshima S, Kubota Y, Sawada T, Watanabe T, Kuroda T, Tsuno N, Higuchi Y, Shinozaki M, Sunouchi K, Masaki T, Saito Y and Muto T: Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas. Dis Colon Rectum 1996, 39:562-567.
14. Rubio CA and Rodensjo M: Mutation of p53 tumor suppressor gene in flat neoplastic lesions of the colorectal mucosa. Dis Colon Rectum 1996, 39:143-147.
15. Rubio CA and Rodensjo M: p53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa. J Cancer Res Clin Oncol 1995, 121:571-576.
16. Neugut AI, Jacobson JS and DeVivo I: Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993, 2:159-176.
17. Hoff G and Vatn MH: Colonic adenoma: natural history. Dig Dis 1991, 9:61-69.
18. Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM and Potter JD: Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002, 11:622-629.
19. Neugut AI, W.C. Lee., Garbowski GC, Waye JD, Forde KA, Treat MR and Fenoglio-Preiser C: Obesity and colorectal adenomatous polyps. J Natl Cancer Inst 1991, 83:359-361.
20. Terry MB and Neugut AI: Smoking and the adenoma-carcinoma sequence. Am J Epidemiol 1998, 147:903-910.
21. Taylor CR, Shi SR, Chiawum B, Young L, Imam SA and Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Human pathology 1994, 25:263-270.
22. Hosmer D.W. Jr, and Lemeshow S: . Applied Logistic Regression New York, Wiley & Sons; 1989:216-238.
23. Rothman KJ and Greenland S: Modern Epidemiology. Philadelphia, Lippincott-Raven; 1998:329-342.
24. Peipins LA and Sandler RS: Epidemiology of colorectal adenomas. Epidemiol Rev 1994, 16: 273-297.
25. Diez M, Medrano M, Muguerza JM, Ramos P, Hernandez P, Villeta R, Martin A, Noguerales F, Ruiz A and Granell J: Influence of tumor localization on the prognostic value of p53 protein in colorectal adenocarcinomas. Anticancer Res 2000, 20:3907-3912.
26. Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Zhang ZF, Black JD, Satchidanand S and Asirwatham JE: The relationship between smoking exposure and p53 overexpression in colorectal cancer. Br J Cancer 1996, 73:902-908.
27. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, Schaffer D, Potter J, Leppert M and Samowitz WS: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000, 92:1831-1836.
28. Laurent-Puig P, Blons H and Cugnenc PH: Sequence of molecular genetic events in colorectal tumorigenesis. Eur J Cancer Prev. 1999, 9:S39-47.
29. Neugut AI and Terry MB: Cigarette smoking and microsatellite instability: causal pathway or marker-defined subset of colon tumors? J Natl Cancer Inst. 2000, 92:1791-1793.
30. Harris CC: 1995 Deichmann Lecture - p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicology Letters 1995, 82-83:1-7.
31. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 1991, 253 (5015):49-53.
32. Fredrikson M, Axelson O, Sun XF, Arbman G, Nilsson E, Nordenskjold B, Sjodahl R and Soderkvist P: A pilot study on risk factors and p53 gene expression in colorectal cancer. Br J Cancer 1996, 73:1428-1430.
33. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T and Kuwano H: Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 2001, 167:65-72.
34. Olshan AF, Weissler MC, Pei H and Conway K: p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev 1997, 6:499-504.
35. Terry MB, Neugut AI, Bostick RM, Potter JD, Haile RW and Fenoglio-Preiser CM: Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2002, 11:660-663.
36. Terry MB, Gammon MD, Ng-Mak D and Thompson WD: Re: "p53 protein overexpression in relation to risk factors for breast cancer". Am J Epidemiol 1998, 147:511-512.